# Commission Decision of 29 September 2006 concerning a financial contribution from the Community towards a baseline survey on the prevalence of Salmonella in slaughter pigs to be carried out in the Member States (notified under document number C(2006) 4306) (2006/668/EC), Division 4.5: Testing of anti-microbial susceptibility

Extent: E+W+S+N.I.

In case of testing for anti-microbial susceptibility (optional), a validated and controlled method for testing shall be used, such as those recommended by the National Committee for Clinical Laboratory Standards (NCCLS, since 1 January 2005: ‘Clinical and Laboratory Standards Institute’ — CLSI).
Both agar diffusion and broth dilution methods are acceptable. Results shall be reported both as quantitative data (MIC for dilution methods and inhibition zone diameter for diffusion methods) and as qualitative data (proportion resistant isolates). Qualitative data shall be based on interpretation according to epidemiological cut-off values presented by the European Committee on Antimicrobial Susceptibility Testing (EUCAST) at: http://www.eucast.org
The isolates shall be tested for the susceptibility to the antimicrobial substances listed below:
Ampicillin or Amoxicillin,
Tetracycline,
Chloramphenicol,
Florfenicol,
Nalidixic acid,
Ciprofloxacin (preferably) or Enrofloxacin,
Sulphonamide (preferably Sulfametoxazole),
Sulphonamide/Trimethoprim or Trimethoprim,
Gentamicin,
Streptomycin,
Kanamycin (preferably) or Neomycin,
third generation Cephalosporin, (preferably Cefotaxime),
Colistin (optional).
Before initiation of the study Member States are encouraged to organise training for the involved parties.

---
Source: https://www.legislation.gov.uk/eudn/2006/668/annex/I/division/4/division/4.5 (the official version)
Page: https://openlegislation.uk/eu-decision-2006-668/annex-I/division-4/division-4.5
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.